Befotertinib is a chemical compound under investigation as an active pharmaceutical ingredient. It is being studied in clinical trials for advanced EGFR-mutant lung cancer.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Befotertinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Osimertinib
pharmaceutical raw material
Osimertinib mesylate
pharmaceutical raw material
Ethacridine lactate
pharmaceutical raw material
Formoterol fumarate dihydrate
pharmaceutical raw material
Pyrilamine tannate
pharmaceutical raw material
Salcaprozic acid
pharmaceutical raw material
Mobocertinib
pharmaceutical raw material
Mobocertinib succinate
pharmaceutical raw material
The international HS code for Befotertinib (CAS 1835667-63-4) is 2933.59.
2933.59
2933 59 95
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-[1-(2,2,2-trifluoroethyl)indol-3-yl]pyrimidin-2-yl]amino]phenyl]prop-2-enamide
USOCZVZOXKTJTI-UHFFFAOYSA-N
CN(C)CCN(C)C1=CC(=C(C=C1NC(=O)C=C)NC2=NC=CC(=N2)C3=CN(C4=CC=CC=C43)CC(F)(F)F)OC
Sourcing Befotertinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.